PharmaCyte Biotech, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q2 2016 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
PharmaCyte Biotech, Inc. annual/quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q2 2016 to Q2 2022.
  • PharmaCyte Biotech, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending July 31, 2022 was $0.000, a 100% decline year-over-year.
  • PharmaCyte Biotech, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $0.000, a 100% decline from 2021.
  • PharmaCyte Biotech, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $509.000, a 77.5% decline from 2020.
  • PharmaCyte Biotech, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2020 was $2.27K, a 400% increase from 2019.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 $0 -$467 -100% May 1, 2022 Jul 31, 2022 10-Q 2022-09-14
Q2 2021 $467 +$79.00 +20.4% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q2 2020 $388 +$388 May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q2 2019 $0 May 1, 2019 Jul 31, 2019 10-Q 2020-09-11
Q2 2017 $0 -$569 -100% May 1, 2017 Jul 31, 2017 10-Q 2017-09-13
Q2 2016 $569 May 1, 2016 Jul 31, 2016 10-Q 2017-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.